Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The F. Dohmen Co. is a Milwaukee-based healthcare organization with a legacy spanning over 160 years in the life sciences industry. Originally established in 1858 as a wholesale apothecary, the company grew into a prominent pharmaceutical wholesaler and later a comprehensive service provider for drug and device manufacturers through its Dohmen Life Science Services (DLSS) division. In 2018, the company divested its commercial services business to private equity firms, which merged those assets to form EVERSANA. Following this sale, Dohmen transitioned into a Social Purpose Corporation, pivoting its mission toward the "food as medicine" movement. Today, the company focuses on addressing the root causes of chronic disease through nutrition-based health solutions and community-focused initiatives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The F. Dohman Company.